Richter, J. R., Shukla, P., Kapetanakis, V., Purser, M., Sapra, S., Boytsov, N., Ballew, N. (2026). Comparative efficacy of belantamab mafodotin plus bortezomib and dexamethasone (BVd) vs standard of care in patients with relapsed/refractory multiple myeloma (RRMM).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7568